MULTILEVEL DETERMINANTS OF HUMAN PAPILLOMAVIRUS VACCINE ACCEPTANCE AND UPTAKE, AND CERVICAL CANCER SCREENING UPTAKE, AMONG WOMEN ATTENDING TERTIARY HEALTHCARE FACILITIES IN NASARAWA STATE, NIGERIA: A CROSS-SECTIONAL STUDY
Nigeria introduced the human papillomavirus (HPV) vaccine into its national routine immunization programme in October 2023, yet population-level data on vaccine acceptance, actual uptake, and cervical cancer screening remain limited, particularly in north-central Nigeria. This study examined the prevalence and multilev...